1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Who would stay longer than 3 mos post merger??

Discussion in 'Allos Therapeutics' started by Anonymous, Jul 21, 2011 at 8:13 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    WHat a dumbass move by both companies. With mixture of culture, reps, and managers, what rep in their right mind would stay more than 3 mos before finding a new gig?
    Actually, only dead weight would stay, the good clinical reps from Allos with connections will be gone fast....the merging company faces SIGNIFICANT challenges with regards to this and other key factors.
     
  2. Anonymous

    Anonymous Guest

    You will not have a choice, you will all lose your jobs with very little severance. Amag is notorious for firing with almost nothing. Guaranteed you will all lose your jobs and Amag will keep their little boys club going with a few of you. Ask any former Amag amployee and there are literally hundreds of them. Amag turnover has been extensive.
     
  3. Anonymous

    Anonymous Guest

    The only people that will be standing when its over are Berns and Allen. Everyone else is out.
     
  4. Anonymous

    Anonymous Guest

    Why would Gary The Butthole Surfer still be here?